Release of Consultation Document – New Assessment Pathways

The TGA has released its ‘Consultation: Business process improvements supporting complementary medicines assessment pathways’. It details new business processes associated with regulatory reforms for Complementary Medicines, which are under implementation in response to the Medicines and Medical Devices Regulation (MMDR) Review. The consultation contains a broad amount of information relating to the TGA’s new ‘risk-based approach to regulating complementary medicines: three assessment pathways’, and includes the following topics and questions.

Please click here to read the alert